Abstract
Cell senescence is an artificially reversible condition activated by various factors and characterized by replicative senescence and typical general alteration of cell functions, including extra–cellular secretion. The number of senescent cells increases with age and contributes strongly to the manifestations of aging. For these reasons, research is under way to obtain “senolytic” compounds, defined as drugs that eliminate senescent cells and therefore reduce aging–associated decay, as already shown in some experiments on animal models. This objective is analyzed in the context of the programmed aging paradigm, as described by the mechanisms of the subtelomere–telomere theory. In this regard, positive effects of the elimination of senescent cells and limits of this method are discussed. For comparison, positive effects and limits of telomerase activation are also analyzed, as well of the combined action of the two methods and the possible association of opportune gene modifications. Ethical issues associated with the use of these methods are outlined.
Similar content being viewed by others
References
Ben–Porath, I., and Weinberg, R. A. (2005) The signals and pathways activating cellular senescence, Int. J. Biochem. Cell Biol., 37, 961–976.
d’Adda di Fagagna, F., Reaper, P. M., Clay–Farrace, L., Fiegler, H., Carr, P., Von Zglinicki, T., Saretzki, G., Carter, N. P., and Jackson, S. P. (2003) A DNA damage checkpoint response in telomere–initiated senescence, Nature, 426, 194–198.
Collado, M., Blasco, M. A., and Serrano, M. (2007) Cellular senescence in cancer and aging, Cell, 130, 223–233.
Acosta, J. C., O’Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., Takatsu, Y., Melamed, J., d’Adda di Fagagna, F., Bernard, D., Hernando, E., and Gil, J. (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence, Cell, 133, 1006–1018.
Cristofalo, V. J., and Pignolo, R. J. (1993) Replicative senescence of human fibroblast–like cells in culture, Physiol. Rev., 73, 617–638.
Shelton, D. N., Chang, E., Whittier, P. S., Choi, D., and Funk, W. D. (1999) Microarray analysis of replicative senescence, Curr. Biol., 9, 939–945.
Zhang, H., Pan, K. H., and Cohen, S. N. (2003) Senescence–specific gene expression fingerprints reveal cell–type–dependent physical clustering of up–regulated chromosomal loci, Proc. Natl. Acad. Sci. USA, 100, 3251–3256.
Campisi, J., and d’Adda di Fagagna, F. (2007) Cellular senescence: when bad things happen to good cells, Nat. Rev. Mol. Cell. Biol., 8, 729–740.
Kirkland, J. L., and Tchkonia, T. (2017) Cellular senescence: a translational perspective, EBioMedicine, 21, 21–28.
Van Deursen, J. M. (2014) The role of senescent cells in ageing, Nature, 509, 439–446.
Coppe, J.–P., Patil, C. K., Rodier, F., Sun, Y., Munoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P. Y., and Campisi, J. (2008) Senescence–associated secretory pheno–types reveal cell–nonautonomous functions of oncogenic RAS and the p53 tumor suppressor, PLoS Biol., 6, 2853–2868.
Rodier, F., Coppe, J. P., Patil, C. K., Hoeijmakers, W. A., Munoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., and Campisi, J. (2009) Persistent DNA damage signalling triggers senescence–associated inflammatory cytokine secretion, Nat. Cell. Biol., 11, 973–979; erratum (2009), 11, 1272.
Wang, E. (1995) Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved, Cancer Res., 55, 2284–2292.
Beausejour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., and Campisi, J. (2003) Reversal of human cellular senescence: roles of the p53 and p16 path–ways, EMBO J., 22, 4212–4222.
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al–Regaiey, K., Su, L., and Sharpless, N. E. (2014) Ink4a/Arf expression is a biomarker of aging, J. Clin. Invest., 114, 1299–1307.
Childs, B. G., Durik, M., Baker, D. J., and van Deursen, J. M. (2015) Cellular senescence in aging and age–related disease: from mechanisms to therapy, Nat. Med., 21, 1424–1435.
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., Saltness, R. A., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., and van Deursen, J. M. (2016) Naturally occurring p16(Ink4a)–positive cells shorten healthy lifespan, Nature, 530, 184–189.
Baker, D. J., Jeganathan, K. B., Cameron, J. D., Thompson, M., Juneja, S., Kopecka, A., Kumar, R., Jenkins, R. B., de Groen, P. C., Roche, P., and van Deursen, J. M. (2004) BubR1 insufficiency causes early onset of aging–associated phenotypes and infertility in mice, Nat. Genet., 36, 744–749.
Baker, D. J., Perez–Terzic, C., Jin, F., Pitel, K. S., Niederlander, N. J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H. J., Eberhardt, N. L., Terzic, A., and van Deursen, J. M. (2008) Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency, Nat. Cell. Biol., 10, 825–836.
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., and van Deursen, J. M. (2011) Clearance of p16Ink4a–positive senescent cells delays ageing–associated disorders, Nature, 479, 232–236.
Chang, J., Wang, Y., Shao, L., Laberge, R. M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., Luo, Y., Wang, X., Aykin–Burns, N., Krager, K., Ponnappan, U., Hauer–Jensen, M., Meng, A., and Zhou, D. (2016) Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice, Nat. Med., 22, 78–83.
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., O’Hara, S. P., LaRusso, N. F., Miller, J. D., Roos, C. M., Verzosa, G. C., LeBrasseur, N. K., Wren, J. D., Farr, J. N., Khosla, S., Stout, M. B., McGowan, S. J., Fuhrmann–Stroissnigg, H., Gurkar, A. U., Zhao, J., Colangelo, D., Dorronsoro, A., Ling, Y. Y., Barghouthy, A. S., Navarro, D. C., Sano, T., Robbins, P. D., Niedernhofer, L. J., and Kirkland, J. L. (2015) The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs, Aging Cell, 14, 644–658.
Fuhrmann–Stroissnigg, H., Ling, Y. Y., Zhao, J., McGowan, S. J., Zhu, Y., Brooks, R. W., Grassi, D., Gregg, S. Q., Stripay, J. L., Dorronsoro, A., Corbo, L., Tang, P., Bukata, C., Ring, N., Giacca, M., Li, X., Tchkonia, T., Kirkland, J. L., Niedernhofer, L. J., and Robbins, P. D. (2017) Identification of HSP90 inhibitors as a novel class of senolytics, Nat. Commun., 8,422.
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., Mazula, D. L., Brooks, R. W., Fuhrmann–Stroissnigg, H., Pirtskhalava, T., Prakash, Y. S., Tchkonia, T., Robbins, P. D., Aubry, M. C., Passos, J. F., Kirkland, J. L., Tschumperlin, D. J., Kita, H., and Le Brasseur, N. K. (2017) Cellular senescence mediates fibrotic pulmonary disease, Nat. Commun., 8, 14532.
Jeon, O. H., Kim, C., Laberge, R. M., Demaria, M., Rathod, S., Vasserot, A. P., Chung, J. W., Kim, D. H., Poon, Y., David, N., B1aker, D. J., van Deursen, J. M., Campisi, J., and Elisseeff, J. H. (2017) Local clearance of senescent cells attenuates the development of post–traumatic osteoarthritis and creates a pro–regenerative environment, Nat. Med., 23, 775–781.
Baar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., van der Pluijm, I., Essers, J., van Cappellen, W. A., van Ijcken, W. F., Houtsmuller, A. B., Pothof, J., de Bruin, R. W. F., Madl, T., Hoeijmakers, J. H. J., Campisi, J., and de Keizer, P. L. J. (2017) Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging, Cell, 169, 132–147.
Yosef, R., Pilpel, N., Tokarsky–Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., Ben–Porath, I., and Krizhanovsky, V. (2016) Directed elimination of senescent cells by inhibition of BCL–W and BCL–XL, Nat. Commun., 7, 11190.
Libertini, G. (1988) An adaptive theory of the increasing mortality with increasing chronological age in populations in the wild, J. Theor. Biol., 132, 145–162.
Holmes, D. J., and Austad, S. N. (1995) Birds as animal models for the comparative biology of aging: a prospectus, J. Gerontol. A Biol. Sci., 50, B59–B66.
Nussey, D. H., Froy, H., Lemaitre, J. F., Gaillard, J. M., and Austad, S. N. (2013) Senescence in natural populations of animals: widespread evidence and its implications for bio–gerontology, Ageing Res. Rev., 12, 214–225.
Jones, O. R., Scheuerlein, A., Salguero–Gomez, R., Camarda, C. G., Schaible, R., Casper, B. B., Dahlgren, J. P., Ehrlen, J., Garcia, M. B., Menges, E. S., Quintana–Ascencio, P. F., Caswell, H., Baudisch, A., and Vaupel, J. W. (2014) Diversity of ageing across the tree of life, Nature, 505, 169–173.
Finch, C. E. (1990) Longevity, Senescence, and the Genome, The University of Chicago Press, Chicago.
Comfort, A. (1979) The Biology of Senescence, Elsevier North Holland, New York.
Medvedev, Z. A. (1990) An attempt at a rational classification of theories of ageing, Biol. Rev. Camb. Philos. Soc., 65, 375–398.
Weinert, B. T., and Timiras, P. S. (2003) Invited review: theories of aging, J. Appl. Physiol., 95, 1706–1716.
Libertini, G. (2015) Non–programmed versus programmed aging paradigm, Curr. Aging Sci., 8, 56–68.
Medawar, P. B. (1952) An Unsolved Problem in Biology, H. K. Lewis, London. Reprinted in: Medawar, P. B. (1957) The Uniqueness of the Individual, Methuen, London.
Hamilton, W. D. (1966) The moulding of senescence by natural selection, J. Theor. Biol., 12, 12–45.
Edney, E. B., and Gill, R. W. (1968) Evolution of senescence and specific longevity, Nature, 220, 281–282.
Mueller, L. D. (1987) Evolution of accelerated senescence in laboratory populations of Drosophila, Proc. Natl. Acad. Sci. USA, 84, 1974–1977.
Williams, G. C. (1957) Pleiotropy, natural selection and the evolution of senescence, Evolution, 11, 398–411.
Rose, M. R. (1991) Evolutionary Biology of Aging, Oxford University Press, New York.
Kirkwood, T. B. (1977) Evolution of ageing, Nature, 270, 301–304.
Kirkwood, T. B., and Holliday, R. (1979) The evolution of ageing and longevity, Proc. R. Soc. Lond. B Biol. Sci., 205, 531–546.
Skulachev, V. P. (1997) Aging is a specific biological function rather than the result of a disorder in complex living systems: biochemical evidence in support of Weismann’s hypothesis, Biochemistry (Moscow), 62, 1191–1195.
Libertini, G. (2012) Classification of phenoptotic phenomena, Biochemistry (Moscow), 77, 707–715.
Skulachev, V. P. (1999) Phenoptosis: programmed death of an organism, Biochemistry (Moscow), 64, 1418–1426.
Libertini, G. (2009) The role of telomere–telomerase system in age–related fitness decline, a tameable process, in Telomeres: Function, Shortening and Lengthening (Mancini, L., ed.) Nova Science Publishers, New York, pp. 77–132.
Libertini, G. (2009) Prospects of a longer life span beyond the beneficial effects of a healthy lifestyle, in Handbook on Longevity: Genetics, Diet and Disease (Bentely, J. V., and Keller, M. A., eds.) Nova Science Publishers Inc., New York, pp. 35–95.
Olshansky, S. J., Hayflick, L., and Carnes, B. A. (2002) Position statement on human aging, J. Gerontol. A Biol. Sci. Med. Sci., 57, B292–297.
Hayflick, L. (2007) Biological aging is no longer an unsolved problem, Ann. N. Y. Acad. Sci., 1100, 1–13.
Kirkwood, T. B., and Melov, S. (2011) On the programmed/non–programmed nature of ageing within the life history, Curr. Biol., 21, R701–707.
De Grey, A. D. (2015) Do we have genes that exist to hasten aging? New data, new arguments, but the answer is still no, Curr. Aging Sci., 8, 24–33.
Gladyshev, V. N. (2016) Aging: progressive decline in fitness due to the rising deleteriome adjusted by genetic, environmental, and stochastic processes, Aging Cell, 15, 594–602.
Kowald, A., and Kirkwood, T. B. (2016) Can aging be programmed? A critical literature review, Aging Cell, 15, 986–998.
Libertini, G. (2008) Empirical evidence for various evolutionary hypotheses on species demonstrating increasing mortality with increasing chronological age in the wild, ScientificWorldJournal, 8, 182–193.
Mitteldorf, J. (2013) Telomere biology: cancer firewall or aging clock? Biochemistry (Moscow), 78, 1054–1060.
Fossel, M. B. (2004) Cells, Aging and Human Disease, Oxford University Press, New York.
Olovnikov, A. M. (2003) The redusome hypothesis of aging and the control of biological time during individual development, Biochemistry (Moscow), 68, 2–33.
Olovnikov, A. M. (2015) Chronographic theory of development, aging, and origin of cancer: role of chronomeres and printomeres, Curr. Aging Sci., 8, 76–88.
Goldsmith, T. C. (2008) Aging, evolvability, and the individual benefit requirement; medical implications of aging theory controversies, J. Theor. Biol., 252, 764–768.
Goldsmith, T. C. (2012) On the programmed/non–programmed aging controversy, Biochemistry (Moscow), 77, 729–732.
Skulachev, M. V., and Skulachev, V. P. (2014) New data on programmed aging–slow phenoptosis, Biochemistry (Moscow), 79, 977–993.
Libertini, G. (2014) The programmed aging paradigm: how we get old, Biochemistry (Moscow), 79, 1004–1016.
Libertini, G., and Ferrara, N. (2016) Possible interventions to modify aging, Biochemistry (Moscow), 81, 1413–1428.
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., and Wu, J. R. (1988) A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes, Proc. Natl. Acad. Sci. USA, 85, 6622–6626.
Blackburn, E. H. (1991) Structure and function of telomeres, Nature, 350, 569–573.
Olovnikov, A. M. (1971) Principle of marginotomy in template synthesis of polynucleotides, Doklady Biochem., 201, 394–397.
Watson, J. D. (1972) Origin of concatemeric T7 DNA, Nat. New Biol., 239, 197–201.
Olovnikov, A. M. (1973) A theory of marginotomy: the incomplete copying of template margin in enzyme synthesis of polynucleotides and biological significance of the problem, J. Theor. Biol., 41, 181–190.
Greider, C. W., and Blackburn, E. H. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts, Cell, 43, 405–413.
Van Steensel, B., and de Lange, T. (1997) Control of telomere length by the human telomeric protein TRF1, Nature, 385, 740–743.
Hayflick, L., and Moorhead, P. S. (1961) The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585–621.
Hayflick, L. (1965) The limited in vitro lifetime of human diploid cell strains, Exp. Cell Res., 37, 614–636.
Blackburn, E. H. (2000) Telomere states and cell fates, Nature, 408, 53–56.
Mefford, H. C., and Trask, B. J. (2002) The complex structure and dynamic evolution of human subtelomeres, Nat. Rev. Genet., 3, 91–102.
Torres, G. A., Gong, Z., Iovene, M., Hirsch, C. D., Buell, C. R., Bryan, G. J., Novak, P., Macas, J., and Jiang, J. (2011) Organization and evolution of subtelomeric satellite repeats in the potato genome, G3 (Bethesda), 1, 85–92.
Gottschling, D. E., Aparicio, O. M., Billington, B. L., and Zakian, V. A. (1990) Position effect at S. cerevisiae telomeres: reversible repression of Pol II transcription, Cell, 63, 751–762.
Libertini, G. (2015) Phylogeny of aging and related phenoptotic phenomena, Biochemistry (Moscow), 80, 1529–1546.
Kerr, J. F. R., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide–ranging implications in tissue kinetics, Br. J. Cancer, 26, 239–257.
Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. (1980) Cell death: the significance of apoptosis, Int. Rev. Cytol., 68, 251–306.
Lynch, M. P., Nawaz, S., and Gerschenson, L. E. (1986) Evidence for soluble factors regulating cell death and cell proliferation in primary cultures of rabbit endometrial cells grown on collagen, Proc. Natl. Acad. Sci. USA, 83, 4784–4788.
Medh, R. D., and Thompson, E. B. (2000) Hormonal regulation of physiological cell turnover and apoptosis, Cell Tissue Res., 301, 101–124.
Alberts, B., Bray, D., Hopkin, K., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. (2013) Essential Cell Biology, 4th Edn., Garland Science, New York.
Anversa, P., Kajstura, J., Leri, A., and Bolli, R. (2006) Life and death of cardiac stem cells, Circulation, 113, 1451–1463.
Richardson, B. R., Allan, D. S., and Le, Y. (2014) Greater organ involution in highly proliferative tissues associated with the early onset and acceleration of ageing in humans, Exp. Gerontol., 55, 80–91.
Reed, J. C. (1999) Dysregulation of apoptosis in cancer, J. Clin. Oncol., 17, 2941–2953.
Rao, M. S., and Mattson, M. P. (2001) Stem cells and aging: expanding the possibilities, Mech. Ageing Dev., 122, 713–734.
Rando, T. A., and Wyss–Coray, T. (2014) Stem cells as vehicles for youthful regeneration of aged tissues, J. Gerontol. A Biol. Sci. Med. Sci., 69 (Suppl. 1), S39–S42.
Mistriotis, P., and Andreadis, S. T. (2017) Vascular aging: molecular mechanisms and potential treatments for vascular rejuvenation, Ageing Res. Rev., 37, 94–116.
Libertini, G., and Ferrara, N. (2016) Aging of perennial cells and organ parts according to the programmed aging paradigm, Age (Dordr.), 38,35.
Libertini, G. (2017) The feasibility and necessity of a revolution in geriatric medicine, OBM Geriatrics, 1, doi: 10.21926/obm.geriat.1702002.
DePinho, R. A. (2000) The age of cancer, Nature, 408, 248–254.
Libertini, G., Rengo, G., and Ferrara, N. (2017) Aging and aging theories, J. Gerontol. Geriatr., 65, 59–77.
Campisi, J. (1997) The biology of replicative senescence, Eur. J. Cancer, 33, 703–709.
Campisi, J. (2003) Cancer and ageing: rival demons? Nat. Rev. Cancer, 3, 339–349.
Wright, W. E., and Shay, J. W. (2005) Telomere biology in aging and cancer, J. Am. Geriatr. Soc., 53, S292–S294.
Campisi, J. (2000) Cancer, aging and cellular senescence, In vivo, 14, 183–188.
Libertini, G. (2013) Evidence for aging theories from the study of a hunter–gatherer people (Ache of Paraguay), Biochemistry (Moscow), 78, 1023–1032.
Klapper, W., Heidorn, K., Kuhne, K., Parwaresch, R., and Krupp, G. (1998) Telomerase activity in “immortal” fish, FEBS Lett., 434, 409–412.
Klapper, W., Kuhne, K., Singh, K. K., Heidorn, K., Parwaresch, R., and Krupp, G. (1998) Longevity of lobsters is linked to ubiquitous telomerase expression, FEBS Lett., 439, 143–146.
Black, H. (2002) Fishing for answers to questions about the aging process, BioScience, 52, 15–18.
Artandi, S. E., and DePinho, R. A. (2010) Telomeres and telomerase in cancer, Carcinogenesis, 31, 9–18.
Dokal, I. (2000) Dyskeratosis congenita in all its forms, Br. J. Haematol., 110, 768–779.
De Lange, T., and Jacks, T. (1999) For better or worse? Telomerase inhibition and cancer, Cell, 98, 273–275.
Artandi, S. E., Chang, S., Lee, S. L., Alson, S., Gottlieb, G. J., Chin, L., and DePinho, R. A. (2000) Telomere dys–function promotes non–reciprocal translocations and epithelial cancers in mice, Nature, 406, 641–645.
Artandi, S. E. (2002) Telomere shortening and cell fates in mouse models of neoplasia, Trends Mol. Med., 8, 44–47.
Wu, X., Amos, C. I., Zhu, Y., Zhao, H., Grossman, B. H., Shay, J. W., Luo, S., Hong, W. K., and Spitz, M. R. (2003) Telomere dysfunction: a potential cancer predisposition factor, J. Natl. Cancer Inst., 95, 1211–1218.
Ma, H., Zhou, Z., Wei, S., Liu, Z., Pooley, K. A., Dunning, A. M., Svenson, U., Roos, G., Hosgood, H. D., 3rd, Shen, M., and Wei, Q. (2011) Shortened telomere length is associated with increased risk of cancer: a metaanalysis, PLoS One, 6, e20466.
Bernardes de Jesus, B., Vera, E., Schneeberger, K., Tejera, A. M., Ayuso, E., Bosch, F., and Blasco, M. A. (2012) Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer, EMBO Mol. Med., 4, 691–704.
Rosen, P. (1985) Aging of the immune system, Med. Hypotheses, 18, 157–161.
Hill, K., and Hurtado, A. M. (1996) Ache Life History, Aldine De Gruyter, New York.
Jazwinski, S. M. (1993) The genetics of aging in the yeast Saccharomyces cerevisiae, Genetica, 91, 35–51.
Fabrizio, P., and Longo, V. D. (2007) The chronological life span of Saccharomyces cerevisiae, Methods Mol. Biol., 371, 89–95.
Laun, P., Bruschi, C. V., Dickinson, J. R., Rinnerthaler, M., Heeren, G., Schwimbersky, R., Rid, R., and Breitenbach, M. (2007) Yeast mother cell–specific ageing, genetic (in)stability, and the somatic mutation theory of ageing, Nucleic Acids Res., 35, 7514–7526.
Kuilman, T., Michaloglou, C., Vredeveld, L. C., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., and Peeper, D. S. (2008) Oncogene–induced senescence relayed by an interleukin–dependent inflammatory network, Cell, 133, 1019–1031.
Demaria, M., O’Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., Alston, S., Academia, E. C., Kilmarx, S., Valdovinos, A., Wang, B., de Bruin, A., Kennedy, B. K., Melov, S., Zhou, D., Sharpless, N. E., Muss, H., and Campisi, J. (2017) Cellular senescence promotes adverse effects of chemotherapy and cancer relapse, Cancer Discov., 7, 165–176.
Biran, A., Zada, L., Abou Karam, P., Vadai, E., Roitman, L., Ovadya, Y., Porat, Z., and Krizhanovsky, V. (2017) Quantitative identification of senescent cells in aging and disease, Aging Cell, 16, 661–671.
Campisi, J. (2013) Aging, cellular senescence, and cancer, Annu. Rev. Physiol., 75, 685–705.
Jaskelioff, M., Muller, F. L., Paik, J. H., Thomas, E., Jiang, S., Adams, A. C., Sahin, E., Kost–Alimova, M., Protopopov, A., Cadinanos, J., Horner, J. W., Maratos–Flier, E., and Depinho, R. A. (2011) Telomerase reactivation reverses tissue degeneration in aged telomerase–deficient mice, Nature, 469, 102–106.
Harley, C. B., Liu, W., Blasco, M., Vera, E., Andrews, W. H., Briggs, L. A., and Raffaele, J. M. (2011) A natural product telomerase activator as part of a health maintenance program, Rejuvenation Res., 14, 45–56.
Harley, C. B., Liu, W., Flom, P. L., and Raffaele, J. M. (2013) A natural product telomerase activator as part of a health maintenance program: metabolic and cardiovascular response, Rejuvenation Res., 16, 386–395.
Bernardes de Jesus, B., and Blasco, M. A. (2012) Potential of telomerase activation in extending health span and longevity, Curr. Opin. Cell Biol., 24, 739–743.
Lopez–Leon, M., and Goya, R. G. (2017) The emerging view of aging as a reversible epigenetic process, Gerontology, 63, 426–431.
Takahashi, K., and Yamanaka, S. (2013) Induced pluripotent stem cells in medicine and biology, Development, 140, 2457–2461.
De Lazaro, I., Yilmazer, A., and Kostarelos, K. (2014) Induced pluripotent stem (iPS) cells: a new source for cell–based therapeutics? J. Control. Release, 185, 37–44.
Tanabe, K., Takahashi, K., and Yamanaka, S. (2014) Induction of pluripotency by defined factors, Proc. Jpn. Acad. Ser. B Phys. Biol. Sci., 90, 83–96.
Takahashi, K., and Yamanaka, S. (2016) A decade of transcription factor–mediated reprogramming to pluripotency, Nat. Rev. Mol. Cell Biol., 17, 183–193.
Mendelsohn, A. R., Larrick, J. W., and Lei, J. L. (2017) Rejuvenation by partial reprogramming of the epigenome, Rejuvenation Res., 20, 146–150.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2018, Vol. 83, No. 12, pp. 1812–1826.
Rights and permissions
About this article
Cite this article
Libertini, G., Ferrara, N., Rengo, G. et al. Elimination of Senescent Cells: Prospects According to the Subtelomere-Telomere Theory. Biochemistry Moscow 83, 1477–1488 (2018). https://doi.org/10.1134/S0006297918120064
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297918120064